Andreas H. Scheel

University of Cologne — Germany

Medicine · Health Sciences

32h-index3.9kcitations167works16.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(52), Lung Cancer Research Studies(38), Peptidase Inhibition and Analysis(29), Cancer Immunotherapy and Biomarkers(25), Cancer Genomics and Diagnostics(20)

Publications167 total

Optimisation of exosome preservation and storage for diagnostic and therapeutic application
Cryobiology·2024
Benchmark of screening markers for KEAP1/NFE2L2 mutations and joint analysis with the K1N2-score
npj Precision Oncology·2024Open Access
Global Study on the Accuracy of Human Epidermal Growth Factor Receptor 2-Low Diagnosis in Breast Cancer
Archives of Pathology & Laboratory Medicine·2024· 23 citedOpen Access
Upregulation and epigenetic modification of the creatine transporter SLC6A8 in non-small cell lung cancer.
PubMed·2024
Generation of iPSC derived CD19 CAR iNK cells for treatment of autoimmune disorders
The Journal of Immunology·2024
Abstract 5244: SIRPα knockout iPSC-derived macrophages (iMACs) are resistant to CD47-dependent inhibition of phagocytosis and efficiently kill tumor cells in pre-clinical models
Cancer Research·2024· 3 cited
Evolutionary trajectories of small cell lung cancer under therapy
Nature·2024· 90 citedOpen Access
1515 Gene edited iPSC-derived macrophages (iMACs) show increased phagocytosis in pre-clinical tumor models
2023· 1 citedOpen Access
Tumour area infiltration and cell count in endoscopic biopsies of therapy-naive upper GI tract carcinomas by QuPath analysis: implications for predictive biomarker testing
Scientific Reports·2023· 3 citedOpen Access
1329P FIND: A phase II study to evaluate the efficacy of erdafitinib in FGFR-altered NSCLC
Annals of Oncology·2023· 2 cited
Somatic rearrangements causing oncogenic ectodomain deletions of FGFR1 in squamous cell lung cancer
Journal of Clinical Investigation·2023· 9 citedOpen Access
KEAP1/NFE2L2 Pathway Signature Outperforms KEAP1/NFE2L2 Mutation Status and Reveals Alternative Pathway-Activating Mutations in NSCLC
Journal of Thoracic Oncology·2023· 22 citedOpen Access
MET Fusions in NSCLC: Clinicopathologic Features and Response to MET Inhibition
Journal of Thoracic Oncology·2023· 17 citedOpen Access
Clinical characteristics and treatment outcome of patients with advanced non-small-cell lung cancer (NSCLC) and FGFR fusions.
Journal of Clinical Oncology·2023· 2 cited
Movie 4 from Tumor Vessel Normalization, Immunostimulatory Reprogramming, and Improved Survival in Glioblastoma with Combined Inhibition of PD-1, Angiopoietin-2, and VEGF
2023Open Access
Supplementary Figure 3 from Tumor Vessel Normalization, Immunostimulatory Reprogramming, and Improved Survival in Glioblastoma with Combined Inhibition of PD-1, Angiopoietin-2, and VEGF
2023Open Access
Movie 2 from Tumor Vessel Normalization, Immunostimulatory Reprogramming, and Improved Survival in Glioblastoma with Combined Inhibition of PD-1, Angiopoietin-2, and VEGF
2023Open Access
Movie 1 from Tumor Vessel Normalization, Immunostimulatory Reprogramming, and Improved Survival in Glioblastoma with Combined Inhibition of PD-1, Angiopoietin-2, and VEGF
2023Open Access
Supplementary Figure 4 from Tumor Vessel Normalization, Immunostimulatory Reprogramming, and Improved Survival in Glioblastoma with Combined Inhibition of PD-1, Angiopoietin-2, and VEGF
2023Open Access
Supplementary Figure 4 from Tumor Vessel Normalization, Immunostimulatory Reprogramming, and Improved Survival in Glioblastoma with Combined Inhibition of PD-1, Angiopoietin-2, and VEGF
2023Open Access
page 1 of 9Next →

Frequent Co-authors

Jürgen Wolf(19), Reinhard Büttner(18), Matthias Scheffler(13), Sabine Merkelbach‐Bruse(13), Hans‐Ulrich Schildhaus(12), Rieke Fischer(12), Sebastian Michels(12), Reinhard Buettner(11), Lukas C. Heukamp(10), Jana Fassunke(10), Josef Rüschoff(9), Carina Heydt(9), Michaela A. Ihle(8), Lucia Nogová(8), Martin L. Sos(7), Thorsten Persigehl(6), Roman K. Thomas(6), Johannes Brägelmann(6), Richard Riedel(6), Martin Hellmich(6)